Identification of a molecular profile associated with immune status in first-onset schizophrenia patients [0.03%]
首次发作的精神分裂症患者的免疫状态相关分子特征的识别
Marlis Herberth,Hassan Rahmoune,Emanuel Schwarz et al.
Marlis Herberth et al.
Objectives: Alterations in immunological parameters have been reported for schizophrenia although little is known about the effects of inflammatory status on immune-related functional changes at disease onset. Here, we ha...
Psychiatrists' view on the risk factors for aggressive behavior in psychotic patients [0.03%]
精神科医师认为的幻觉患者的暴力行为风险因素
Angela F Nederlof,Gabriela V Koppenol-Gonzalez,Peter Muris et al.
Angela F Nederlof et al.
In meta-analytic studies it was found that patients diagnosed with a psychotic disorder are at increased risk for displaying violent behavior. However, it remains largely unclear which specific factors contribute to the heightened risk for ...
Bernard J Gallagher rd,Brian J Jones
Bernard J Gallagher rd
There are many psychiatric disorders for which severe adverse events in childhood have been shown to be significant risk factors. This is particularly true for schizophrenia. The authors designed this study to determine whether specific chi...
Bone loss associated with hyperprolactinemia in patients with schizophrenia [0.03%]
精神分裂症患者的高催乳素血症相关骨丢失
Bruce J Kinon,Hong Liu-Seifert,Virginia L Stauffer et al.
Bruce J Kinon et al.
Background: Elevated prolactin (hyperprolactinemia) has been commonly reported during treatment with some antipsychotic drugs. A decrease in bone mineral density (BMD) may be related to elevated prolactin. The objective o...
Schizophrenia and relationships: the effect of mental illness on sexuality [0.03%]
精神分裂症与人际关系：心理疾病对性生活的影响
Margareta Östman,Ann-Christine Björkman
Margareta Östman
This paper seeks to investigate the impact of mental illness on the sexuality of patients with a schizophrenic disorder who live in the community in a long-term relationship with a partner. We conducted qualitative, in-depth interviews with...
Marilyn J Miller
Marilyn J Miller
With increased attention being devoted to the metabolic effects of antipsychotic medications, it becomes apparent that efforts need to be made to ensure that patients receiving treatment for a mental illness receive appropriate evaluation a...
Underprescribing of clozapine and unexplained variation in use across hospitals and regions in the Canadian province of Québec [0.03%]
加拿大魁北克省氯氮平处方不足及各医院和地区的使用差异不容忽视
Eric Latimer,Willy Wynant,Robin Clark et al.
Eric Latimer et al.
Background: Clozapine remains the antipsychotic of choice for people who, having met the criteria for a diagnosis of schizophrenia or a related psychotic disorder, do not respond adequately to other antipsychotic medicati...
Joana Teixeira,Teresa Mota,João Cabral Fernandes
Joana Teixeira
Folie à deux is a relatively rare mental disorder first described in France in 1877 by Laségue and Falret. However, folie á deux is still a matter of study and debate today as it remains a challenge for psychiatrists. The aim of our work...
Antipsychotic Adherence Intervention for Veterans over 40 with Schizophrenia: Results of a Pilot Study [0.03%]
针对40岁以上退伍军人精神分裂症患者的抗精神病药物依从性干预：一项试点研究的结果
Dinesh Mittal,Richard R Owen,Jonathan P Lacro et al.
Dinesh Mittal et al.
This pilot study tested the feasibility, acceptability, and effect-sizes of a multimodal, individual intervention designed to optimize antipsychotic medication use in patients >/=40 years of age with schizophrenia or schizoaffective disorde...
Motivating Persons with Schizophrenia Spectrum Disorders to Exercise: Rationale and Design [0.03%]
激励分裂型精神障碍患者运动：理据和设计
Lora Humphrey Beebe,R Burk,K McIntyre et al.
Lora Humphrey Beebe et al.
Persons with schizophrenia spectrum disorders (SSDs) are not only at risk because of disabling disease symptoms but because necessary medications create health risks associated with high rates of obesity. Despite the well-known benefits of ...